Home Tags Healthcare industry updates

Tag: Healthcare industry updates

physician-associates-updated-guidelines-and-best-practices-for-use

Physician Associates: Updated Guidelines and Best Practices for Use

Physician Associates: Updated Guidelines and Best Practices for UseGetty ImagesPhysician Associates (PAs) in the healthcare field are a hot topic of debate, with the Royal College of Physicians (RCP) issuing new guidelines that could...
hims-super-bowl-ad-mpact-usad-freeze-pharmalittle-update

Hims Super Bowl Ad Impact & USAID Freeze: Pharmalittle Update

In the world of pharmaceuticals, two bipartisan lawmakers are raising concerns about a forthcoming Super Bowl ad from Hims & Hers that targets the weight-loss industry. Senators Dick Durbin and Roger Marshall have penned...
china-probes-astrazeneca-super-bowl-ad-pharmalittle-news-update

China probes AstraZeneca, Super Bowl ad: Pharmalittle News Update

China Investigates AstraZeneca and Super Bowl Ad: Pharmalittle News UpdateA recent development in the pharmaceutical industry has raised eyebrows as a pharmaceutical industry group is calling on the U.S. Food and Drug Administration to...
trump-administration-rescinds-drug-pricing-tests-walgreens-faces-opioid-lawsuit

Trump Administration Rescinds Drug-Pricing Tests, Walgreens Faces Opioid Lawsuit

**Trump Administration Rescinds Drug-Pricing Tests, Walgreens Faces Opioid Lawsuit**In a recent turn of events, the Trump administration has rescinded an executive order that led to the creation of three drug-pricing experiments by the Center...
hospital-price-transparency-rules-enhancing-data-usefulness-with-new-updates

Hospital Price Transparency Rules: Enhancing Data Usefulness with New Updates

Hospital Price Transparency Rules: Improving Data Usefulness with Recent UpdatesAs we step into the new year, a wave of fresh updates has been introduced to the federal guidelines regarding hospital price transparency. These changes...
pharmalittle-lilly-drug-shortage-ends-novo-obesity-trial-disappoints-more-latest-updates

Pharmalittle: Lilly Drug Shortage Ends, Novo Obesity Trial Disappoints & More – Latest Updates

Novo Nordisk’s Obesity Trial Disappoints Novo Nordisk, a key player in the pharmaceutical industry, recently faced a setback with their next-generation obesity candidate, CagriSema. The pivotal study results showed that the treatment helped patients lose...